ABLS
Abacus FCF Small Cap Leaders ETF
Abacus FCF Small Cap Leaders ETF seeks to provide investors with long-term capital appreciation by investing in a concentrated portfolio of small-cap companies with strong free cash flow generation.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
1.2 M
ASSETS UNDER MGMT
59 bp
EXPENSES
Fund Basics
| Fund sponsor | Abacus |
| Category | US |
| Asset class | Equity |
| Website | link... |
| Inception date | Feb 18, 2025 |
| Assets (mns) | $1 |
| Expense ratio | 59 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | |
| Taxation | 1099 |
| Stock selection | |
| Weighting | |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ARGAN INC | 4.3 % |
| COLLEGIUM PHARMACEUTICAL, INC. | 3.9 % |
| PJT PARTNERS, INC. CLASS A | 3.5 % |
| ARTISAN PARTNERS ASSET MA -A | 3.3 % |
| ENOVA INTERNATIONAL INC | 2.8 % |
| KONTOOR BRANDS, INC. | 2.8 % |
| SENECA FOODS CORP - CL A | 2.7 % |
| LCI INDUSTRIES | 2.6 % |
| INNOVIVA, INC. | 2.6 % |
| ZURN WATER SOLUTIONS CORPORATION | 2.5 % |
Constituent Breakdown
| Number of holdings | 50 |
| Herfindahl-Hirschman Index | 222 |
| Wgt avg mkt cap (mns) | $2,565 |
| Large cap (>$10bn) | 54.9% |
| Mid cap ($2-10bn) | 44.6% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.5% |
| Emerging mkts. | 0.0% |
Country Exposure
 |
UNITED STATES | 99.3 % |
Historical Performance
Standardized Performance (as of 11/30/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | 15.1% |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | 0.2% |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | 15.3% | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | 22.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.39% |
Technical Indicators
| 30d moving avg. (EMA) | $23.02 |
| Relative strength (RSI) | 52 |
| MACD/Signal | 0.00/-0.07 |
| Bollinger Bands (Upper/Lower) | $23.60/$22.22 |
| Short interest (% of AUM) | 0.0% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ABLS |
Expenses vs. ABLS |
ALTAR Score™ vs. ABLS |
|---|---|---|---|---|
| SIXS | ETC 6 Meridian Small Cap Equity ETF | 15.5% | +30 bp | +9.6% |
| XSHQ | Invesco S&P SmallCap Quality ETF | 13.5% | -30 bp | +7.8% |
| SCOW | Pacer S&P SmallCap 600 Quality FCF Aristocrats ETF | 12.6% | 0 bp | +9.9% |
| CAFG | Pacer US Small Cap Cash Cows Growth Leaders ETF | 12.1% | 0 bp | +6.6% |
| SFLO | VictoryShares Small Cap Free Cash Flow ETF | 11.8% | -10 bp | +10.9% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 10.7% | -24 bp | +9.8% |
Risk and Returns: ABLS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2024 | 2025 | 2026 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 12/2/2025
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
NEUTRAL
Average appreciation potential. A rating of NEUTRAL is assigned to ETFs with ALTAR Scores in the middle quintile (ranking between 40%-60%) of their category. This indicates that valuations adequately reflect the fundamentals of stocks in these funds.
ALTAR Score™
ABLS
5.1%
Cat. Avg
5.7%
ALTAR Score™ Calculation
Category Overview
There are 1012 funds in the US Equity category, with an average ALTAR Score™
of 5.7% and a standard deviation of
2.3%. ABLS's ALTAR Score™ is approximately
0.2 standard deviations
below
the category average. This places ABLS in the 41st percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
ABLSSELL
U/W
HOLD
O/W
BUY